BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Deals

  Johnson & Johnson Selling LifeScan Unit for $2.1 Billion

  Platinum Equity submitted a binding offer to Johnson & Johnson to buy LifeScan for $2.1 billion.

  March 16, 2018

   · 

  3 min read

   · 

  Mark Terry
• 

  Biotech Bay

  Theranos Serves as a Cautionary Tale for Biotech Funding

  There are dangers in biotech funding and Theranos should serve as a warning.

  March 16, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Adaptimmune Sees Positive Early Results in Cancer Treatment

  Adaptimmune reported it saw three partial responses in three of the four myxoid/ round cell liposarcoma (MRCLS) patients the company dosed with its NY-ESO SPEAR T-cells.

  March 16, 2018

   · 

  2 min read

   · 

  Alex Keown